Your browser doesn't support javascript.
loading
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
Wang, Zhaoming; Zhu, Bin; Zhang, Mingfeng; Parikh, Hemang; Jia, Jinping; Chung, Charles C; Sampson, Joshua N; Hoskins, Jason W; Hutchinson, Amy; Burdette, Laurie; Ibrahim, Abdisamad; Hautman, Christopher; Raj, Preethi S; Abnet, Christian C; Adjei, Andrew A; Ahlbom, Anders; Albanes, Demetrius; Allen, Naomi E; Ambrosone, Christine B; Aldrich, Melinda; Amiano, Pilar; Amos, Christopher; Andersson, Ulrika; Andriole, Gerald; Andrulis, Irene L; Arici, Cecilia; Arslan, Alan A; Austin, Melissa A; Baris, Dalsu; Barkauskas, Donald A; Bassig, Bryan A; Beane Freeman, Laura E; Berg, Christine D; Berndt, Sonja I; Bertazzi, Pier Alberto; Biritwum, Richard B; Black, Amanda; Blot, William; Boeing, Heiner; Boffetta, Paolo; Bolton, Kelly; Boutron-Ruault, Marie-Christine; Bracci, Paige M; Brennan, Paul; Brinton, Louise A; Brotzman, Michelle; Bueno-de-Mesquita, H Bas; Buring, Julie E; Butler, Mary Ann; Cai, Qiuyin.
Affiliation
  • Wang Z; Division of Cancer Epidemiology and Genetics, Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Zhu B; Division of Cancer Epidemiology and Genetics.
  • Zhang M; Division of Cancer Epidemiology and Genetics.
  • Parikh H; Division of Cancer Epidemiology and Genetics.
  • Jia J; Division of Cancer Epidemiology and Genetics.
  • Chung CC; Division of Cancer Epidemiology and Genetics, Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Sampson JN; Division of Cancer Epidemiology and Genetics.
  • Hoskins JW; Division of Cancer Epidemiology and Genetics.
  • Hutchinson A; Division of Cancer Epidemiology and Genetics, Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Burdette L; Division of Cancer Epidemiology and Genetics, Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Ibrahim A; Division of Cancer Epidemiology and Genetics.
  • Hautman C; Division of Cancer Epidemiology and Genetics, Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Raj PS; Division of Cancer Epidemiology and Genetics.
  • Abnet CC; Division of Cancer Epidemiology and Genetics.
  • Adjei AA; Korle Bu Teaching Hospital, PO BOX 77, Accra, Ghana, University of Ghana Medical School, PO Box 4236, Accra, Ghana.
  • Ahlbom A; Unit of Epidemiology, Institute of Environmental Medicine.
  • Albanes D; Division of Cancer Epidemiology and Genetics.
  • Allen NE; Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.
  • Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Aldrich M; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Amiano P; Public Health Division of Gipuzkoa, Basque Regional Health Department, San Sebastian, Spain, CIBERESP, CIBER Epidemiologia y Salud Publica, Madrid, Spain.
  • Amos C; Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
  • Andersson U; Department of Radiation Sciences, Oncology.
  • Andriole G; Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO, USA.
  • Andrulis IL; Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mt Sinai Hospital, University of Toronto, Toronto, ON, Canada.
  • Arici C; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy.
  • Arslan AA; Department of Obstetrics and Gynecology and Department of Population Health, New York University School of Medicine, New York, NY, USA, New York University Cancer Institute, New York, NY, USA.
  • Austin MA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Baris D; Division of Cancer Epidemiology and Genetics.
  • Barkauskas DA; Department of Preventive Medicine, Biostatistics Division, Keck School of Medicine and.
  • Bassig BA; Division of Cancer Epidemiology and Genetics, Division of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, USA.
  • Beane Freeman LE; Division of Cancer Epidemiology and Genetics.
  • Berg CD; Division of Cancer Prevention.
  • Berndt SI; Division of Cancer Epidemiology and Genetics.
  • Bertazzi PA; Department of Clinical Sciences and Community Health, University of Milan, Department of Preventive Medicine, Fondazione IRCCS Ca' Granda Policlinico Hospital, Milan, Italy.
  • Biritwum RB; Korle Bu Teaching Hospital, PO BOX 77, Accra, Ghana, University of Ghana Medical School, PO Box 4236, Accra, Ghana.
  • Black A; Division of Cancer Epidemiology and Genetics.
  • Blot W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA, International Epidemiology Institute, Rockville, MD, USA.
  • Boeing H; Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany.
  • Boffetta P; Institute for Translational Epidemiology, Hematology and Medical Oncology, Mount Sinai Hospital School of Medicine, New York, NY, USA.
  • Bolton K; Division of Cancer Epidemiology and Genetics, Department of Oncology, University of Cambridge, Cambridge CB2 2RE, UK.
  • Boutron-Ruault MC; Institut National de la Sante et de la Recherche Medicale (INSERM) and Institut Gustave Roussy, Villejuif, France.
  • Bracci PM; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
  • Brennan P; International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Brinton LA; Division of Cancer Epidemiology and Genetics.
  • Brotzman M; Westat, Rockville, MD, USA.
  • Bueno-de-Mesquita HB; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Buring JE; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Butler MA; Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, OH, USA.
  • Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Hum Mol Genet ; 23(24): 6616-33, 2014 Dec 15.
Article in En | MEDLINE | ID: mdl-25027329
Genome-wide association studies (GWAS) have mapped risk alleles for at least 10 distinct cancers to a small region of 63 000 bp on chromosome 5p15.33. This region harbors the TERT and CLPTM1L genes; the former encodes the catalytic subunit of telomerase reverse transcriptase and the latter may play a role in apoptosis. To investigate further the genetic architecture of common susceptibility alleles in this region, we conducted an agnostic subset-based meta-analysis (association analysis based on subsets) across six distinct cancers in 34 248 cases and 45 036 controls. Based on sequential conditional analysis, we identified as many as six independent risk loci marked by common single-nucleotide polymorphisms: five in the TERT gene (Region 1: rs7726159, P = 2.10 × 10(-39); Region 3: rs2853677, P = 3.30 × 10(-36) and PConditional = 2.36 × 10(-8); Region 4: rs2736098, P = 3.87 × 10(-12) and PConditional = 5.19 × 10(-6), Region 5: rs13172201, P = 0.041 and PConditional = 2.04 × 10(-6); and Region 6: rs10069690, P = 7.49 × 10(-15) and PConditional = 5.35 × 10(-7)) and one in the neighboring CLPTM1L gene (Region 2: rs451360; P = 1.90 × 10(-18) and PConditional = 7.06 × 10(-16)). Between three and five cancers mapped to each independent locus with both risk-enhancing and protective effects. Allele-specific effects on DNA methylation were seen for a subset of risk loci, indicating that methylation and subsequent effects on gene expression may contribute to the biology of risk variants on 5p15.33. Our results provide strong support for extensive pleiotropy across this region of 5p15.33, to an extent not previously observed in other cancer susceptibility loci.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Chromosomes, Human, Pair 5 / Gene Expression Regulation, Neoplastic / Telomerase / Genetic Loci / Membrane Proteins / Neoplasm Proteins / Neoplasms Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Hum Mol Genet Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2014 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Chromosomes, Human, Pair 5 / Gene Expression Regulation, Neoplastic / Telomerase / Genetic Loci / Membrane Proteins / Neoplasm Proteins / Neoplasms Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Hum Mol Genet Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2014 Type: Article Affiliation country: United States